InVivo acquires Syngenta's Bioline

InVivo has signed an agreement to acquire, through its holding company InVivo AgroSciences, Bioline, a subsidiary of Syngenta specialized in the production and marketing of biological control agents, and in particular macro-organisms active against insects pests in fruits, vegetable and flower crops.

 

By joining forces, Bioline and Biotop, a long-standing InVivo subsidiary working in biological pest control, will become a truly global player in a high-potential and fast-growing market. Investing in high-potential businesses to create French champions with critical mass is one of the clearly stated ambitions in the “2025 by InVivo” strategic plan. On the same level as digital agriculture, biosolutions* are among the main future paths that the InVivo group intends to explore as part of its drive to produce more and better. 

 

Strengthened by its long-standing know-how with its subsidiary Biotop, the acquisition of Bioline will enable InVivo to build the capacities required to develop a significant activity in biosolutions. The growth of this USD 2.8 billion market is estimated at 10% a year for the coming ten years.

 

Bioline is highly present in the macro-organisms market and more specifically in mites in northern Europe used against predatory insects in greenhouse crops. Biotop has a bioplant in the Drôme department in France, specialised notably in the production of ephestia eggs (used for raising auxiliaries) and trichogramma (micro-wasps that fight against corn borers).

 

The two companies make a highly complementary fit through their expertise in arable crops and specialised crops, their geographical presence in France and internationally, and their portfolio of macro-organisms.